The True Cost of Poor Health
What Chronic Illness Takes From You and Your Loved Ones
An in-depth look at where the $5.3 trillion actually goes, and why the number on your bill is only ever part of the story.
Most people measure the cost of their health one visit at a time. A co-pay here, a prescription refill there, a specialist appointment every few months.
Each of these feels manageable in isolation. What rarely gets calculated is the sum of all of them, compounded over years, alongside a cost that never appears on any invoice at all: the time, energy, and options a chronic condition quietly takes from someone’s life.
The Number Behind the Number
What “90%” Actually Measures
Ninety percent of the nation’s $5.3 trillion in annual healthcare spending is attributable to people managing at least one chronic or mental health condition, according to the Centers for Disease Control and Prevention.[1]
That’s a broader measure than it might first sound. It captures the full healthcare spending of people who have a chronic condition, not only the portion spent specifically managing that condition, since a person with a musculoskeletal condition still generates other healthcare costs unrelated to it. Even accounting for that distinction, the figure reflects something real: most Americans carry at least one chronic condition, and their overall care needs now dominate the nation’s healthcare spending.[1]
That headline figure is easy to read past. It’s worth breaking into pieces that are actually easier to picture.
Two Conditions, Hundreds of Billions of Dollars
Musculoskeletal disorders (arthritis, back pain, and related conditions)
Affect more than 1 in 3 U.S. adults and account for over $300 billion in direct medical spending, more than any other single chronic condition category, plus 290 million lost workdays a year, the leading cause of workplace absenteeism of any major health condition.[2]
Neurocognitive disorders
An estimated $409 billion in direct health and long-term care costs in 2026, projected to approach $1 trillion annually by 2050 as the affected population grows.[3]
These aren’t small, isolated line items. They’re two examples, both closely tied to aging, inside a much larger pattern, one where the majority of national healthcare spending traces back to conditions that, once established, tend to be managed indefinitely rather than resolved.
Direct Costs Are Just the Opening Bid
What Counts as “Direct”
The direct costs of a chronic condition are the easiest to see: medications, procedures, specialist visits, hospital stays. These are what most healthcare cost conversations focus on, largely because they’re the easiest to quantify and the easiest to put on an invoice.
Why Costs Compound When Conditions Do
Direct costs alone rarely tell the full financial story of a single condition, let alone a person managing several at once. A patient with a chronic musculoskeletal condition often also manages related issues that tend to arrive alongside it as they age, from reduced mobility to secondary joint or connective-tissue involvement elsewhere in the body.
Research on multimorbidity, the presence of two or more chronic conditions in the same patient, has found that overlapping conditions compound their impact on a patient’s quality of life in ways that a single-diagnosis view doesn’t capture.[4] It stands to reason that a similar compounding effect applies to cost, since each additional diagnosis adds its own layer of monitoring and care rather than replacing what came before it.
A person managing three related chronic conditions isn’t paying three separate, unrelated bills. They’re paying for three overlapping care plans that often duplicate monitoring, interact with one another, and require more coordination between specialists than any single diagnosis would on its own.
The Costs That Never Make It to a Balance Sheet
Why Indirect Costs Are Easy to Underestimate
The indirect costs of chronic illness are harder to see and easier to underestimate, precisely because no single invoice captures them. Lost work productivity, missed time with family, and the cumulative toll of managing a condition rather than resolving it all carry real financial weight, even without a line item attached.
Neurocognitive Disorders, Broken All the Way Down
Neurocognitive disorders offer an unusually detailed picture of what “indirect cost” actually breaks down into, thanks to a comprehensive 2026 cost model funded by the National Institute on Aging. Of this category’s total estimated $818 billion in annual societal cost, the breakdown looks different from what most people assume:[3]
- $320 billion from reduced quality of life for people living with a neurocognitive disorder, the single largest cost category
- $237 billion from unpaid care provided by family and friends
- $23 billion in earnings losses, split between patients and their caregivers
Notice what’s missing from that list: a majority of the true cost isn’t direct medical spending at all. Only about 27 cents of every dollar flows through the health system. The rest is absorbed elsewhere, in ways a standard healthcare cost report doesn’t capture.
A Pattern That Holds Beyond Neurocognitive Disorders
Research on the broader economic burden of chronic disease consistently finds this same pattern holding across conditions generally, not just neurocognitive disorders: indirect costs, lost productivity, disability, and reduced workforce participation, rivaling or exceeding the direct medical spending associated with the same conditions once both are fully accounted for.[5]
The Second Shift Nobody Gets Paid For
Who Actually Absorbs This Cost
That $237 billion in unpaid caregiving for neurocognitive disorders above isn’t an isolated figure. It’s one piece of a much larger category of indirect cost that doesn’t show up in any disease-specific report at all, because it isn’t billed to the patient. It’s absorbed by the people around them.
Family caregivers in the United States now provide an estimated $1.01 trillion in unpaid care annually, according to AARP’s most recent research:[6]
- 59 million people providing ongoing care
- 49.5 billion hours of care annually
- Equivalent labor to roughly 24 million full-time workers, close to 17% of the entire U.S. full-time workforce
That’s work that mostly goes unpaid and frequently goes unrecognized as work at all, and caregiving for neurocognitive disorders alone accounts for more than 19 billion of those hours.[3]
The Cost Caregivers Absorb Personally
The financial toll on caregivers themselves is direct and personal, not abstract. Reduced work hours, skipped promotions, and early job exits are common among family caregivers, separate from and in addition to the $1.01 trillion figure above, which measures the value of the care provided rather than what caregivers themselves give up in their own careers.[6]
A retirement account that stops growing because someone cut back to part-time to manage a parent’s care, or a career pause that becomes permanent, rarely gets counted in a national chronic disease cost estimate. It’s still a cost. It’s simply paid by someone standing next to the patient rather than the patient alone.
This is, for many families, the most viscerally felt version of the true cost of bad health: not a number on anyone’s bill, but a second, unpaid job that shows up alongside a first one, often for years, often for a condition that was never fully resolved in the first place.
From Managing Symptoms to Changing the Math
A Different Framework for Care
Existing fee-for-service models of care have historically prioritized symptom management, medications, and procedures over addressing the root causes of a condition through more foundational changes to a patient’s underlying biology.[7] Researchers studying this pattern have proposed a different framework entirely, one built around what’s sometimes called the quadruple aim:
- Improved population health
- A better patient experience
- Reduced overall healthcare costs
- Less burnout among the clinicians providing care
Achieving that combination requires care models that look upstream of a symptom rather than only downstream of it, and upstream is exactly where both the presenteeism data and the caregiving burden above actually originate.[7]
Where Regenerative Medicine Fits
Regenerative medicine applies this same logic at a much smaller scale: one patient at a time. Rather than asking only how to manage a symptom, it also asks what may be contributing to the body’s underlying environment and whether supporting natural repair processes may be appropriate.
This isn’t a claim that regenerative approaches are right for every condition or every patient, and it isn’t a case against traditional medicine, which remains the appropriate choice for acute trauma, infections, and emergencies. It’s a different kind of investment, weighed against a different long-term pattern, one worth understanding fully before assuming the visible bill, or even the visible indirect costs, is the whole story.
The true cost of bad health was never just the number on a single invoice. It’s the compounding total of years spent managing a condition rather than resolving it, plus the lost productivity, caregiving burden, and quality of life that don’t show up on any statement at all.
Musculoskeletal disorders and neurocognitive disorders alone account for well over a trillion dollars a year in costs most people never see broken down this way, and each is only one piece of a $5.3 trillion pattern built on the long-term management of chronic illness. Understanding that fuller picture, and how a regenerative approach may fit into it, is a conversation worth having directly with a qualified clinician, not something to work out from a bill alone.
To explore how a personalized care plan might apply to your situation, find a Genesis clinician or review our patient education resources.
Frequently Asked Questions (FAQs)
Are these national cost figures skewed by a small number of extremely expensive conditions?
Not entirely. While musculoskeletal disorders and neurocognitive disorders are individually among the largest contributors, the CDC’s broader 90%-of-spending figure spans chronic disease and mental health conditions collectively, not a handful of outlier diagnoses. The pattern is broad rather than concentrated in just one or two categories
Does prevention actually reduce these costs, or does it just delay them to later in life?
Research on preventive and lifestyle-focused care suggests genuine cost reduction rather than simple deferral, particularly when intervention happens before a condition becomes fully established. That said, individual outcomes vary, and this is a question worth discussing directly with a clinician familiar with a patient’s specific history.
I’m a caregiver, not the patient. Does any of this apply to me?
Directly, yes. The AARP figures above capture unpaid family caregivers specifically, and the toll on a caregiver’s own career, finances, and wellbeing is a real cost of a loved one’s chronic condition, even though it’s rarely counted as one. It’s a reasonable thing to raise in a conversation with a clinician alongside the patient’s own care plan.
How does regenerative medicine fit into this cost conversation specifically?
Regenerative approaches don’t eliminate the direct or indirect costs of chronic conditions on their own. What they offer is a different starting question, focused on the underlying environment in addition to symptom management, which may change the long-term cost pattern for some patients. That’s a determination best made with a qualified clinician, not a general claim that applies to every condition.
Is this post saying traditional medicine is a bad investment?
No. Traditional medicine remains the appropriate choice for acute trauma, infections, and emergencies. This discussion is specifically about chronic, ongoing conditions, where a different approach to cost and outcome may be worth understanding.
References
- Centers for Disease Control and Prevention. Fast Facts: Health and Economic Costs of Chronic Conditions. National Center for Chronic Disease Prevention and Health Promotion. 2026. https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html
- United States Bone and Joint Initiative / Orthopaedic Research Society. Burden of Musculoskeletal Diseases in the United States (BMUS). 2024. https://bmus-ors.org/
- Thunell J, et al. U.S. Cost of Dementia, 2026. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2026. https://schaeffer.usc.edu/research/dementia-cost-us-818-billion-2026-study/; supplementary figures from Alzheimer’s Association. 2026 Alzheimer’s Disease Facts and Figures. https://www.alz.org/alzheimers-dementia/facts-figures
- Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and Quality of Life: Systematic Literature Review and Meta-Analysis. Ageing Research Reviews. 2019;53:100903. https://doi.org/10.1016/j.arr.2019.04.005
- Waters H, Graf M. The Costs of Chronic Disease in the U.S. Milken Institute. 2018. https://milkeninstitute.org/content-hub/research-and-reports/reports/costs-chronic-disease-us
- AARP Public Policy Institute. Valuing the Invaluable 2026: The Growing Economic Value of Family Caregiving. AARP. 2026. https://www.aarp.org/caregiving/financial-legal/valuing-the-invaluable-report-2026/
- Livingston KA, et al. Lifestyle Medicine and Economics: A Proposal for Research Priorities Informed by a Case Series of Disease Reversal. International Journal of Environmental Research and Public Health. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8583680/ (https://doi.org/10.3390/ijerph182111364)
